
|Articles|February 1, 2004
Formularies, generics force change
I am constantly impressed by the perceptions and misconceptions of my patients, which gives me cause to sit and reflect a moment on how our lives are shaped by marketing and economic forces that go unrecognized by most.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
3
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














